{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03119584","recordId":"NCT03119584","peptideSlug":"linaclotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03119584-linaclotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03119584.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03119584.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2017-04-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"linaclotide","submittedDate":"2017-04-17","publishedAt":"2026-08-23","recordId":"NCT03119584","recordSha256":"8055045b1169c1757094bd1010548936d87ad6030d8f4249c438db0ab7ca6391","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03119584?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2017-05-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"linaclotide","submittedDate":"2017-05-03","publishedAt":"2026-08-23","recordId":"NCT03119584","recordSha256":"054f74e3b490bfb6c871e31029366171ccde6ad8c36a6eea97a6bd2cd00ee464","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03119584?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Conditions","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2018-04-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"linaclotide","submittedDate":"2018-04-23","publishedAt":"2026-08-23","recordId":"NCT03119584","recordSha256":"7bff9e3943d1b67f306f8854e922a297e71321fdb63b3313b19898461a3ff992","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03119584?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2019-05-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"linaclotide","submittedDate":"2019-05-09","publishedAt":"2026-08-23","recordId":"NCT03119584","recordSha256":"796d0060f7caae3d8c9f094dcf39c4c9da6c385ec76f8149286a3fcfeb1baecb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03119584?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2019-05-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"linaclotide","submittedDate":"2019-05-23","publishedAt":"2026-08-23","recordId":"NCT03119584","recordSha256":"e123f7f2385723e191f366c0730ece04acf2ec514338541d254745ecc182924c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03119584?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2020-02-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"linaclotide","submittedDate":"2020-02-21","publishedAt":"2026-08-23","recordId":"NCT03119584","recordSha256":"7654d8968d20837d6b37ed5db592f08cf128792fcb8deb6fbeb710e634f9a02f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03119584?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2021-03-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"linaclotide","submittedDate":"2021-03-30","publishedAt":"2026-08-23","recordId":"NCT03119584","recordSha256":"648f4165008e97ae2d1f32c50c2880c9fe761f9eced4f5d747116eada148c618","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03119584?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2022-04-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"linaclotide","submittedDate":"2022-04-08","publishedAt":"2026-08-23","recordId":"NCT03119584","recordSha256":"be07e461ed29e43a75c07a65b2a73ca362a36956503b39f13cbd81000eaca65f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03119584?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2023-04-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"linaclotide","submittedDate":"2023-04-28","publishedAt":"2026-08-23","recordId":"NCT03119584","recordSha256":"f3f908c3afc777400eae0e6c2196a0898fe9dc82a421e26c3b82c319886e12bd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03119584?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2024-02-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"linaclotide","submittedDate":"2024-02-12","publishedAt":"2026-08-23","recordId":"NCT03119584","recordSha256":"fe1d1170332d54ee7cc58f20b8f11fb02ff1a10aea9a316626361e14a74e7e5c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03119584?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2026-03-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"linaclotide","submittedDate":"2026-03-30","publishedAt":"2026-08-23","recordId":"NCT03119584","recordSha256":"4b6a10a690c8e1a86b0b4a5ff924648cef306e4a451847e60f97c3cbf3ba029a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03119584?a=11&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"ae6cf9b37e6e67ded6af53232cddded5341b29a06259d8ff9a87764fbebd7195"}}